Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
Submitted by
admin
on November 16, 2009 - 10:33am
Source:
InVivo
News Tags:
Fate Therapeutics
Genzyme
Astellas
Headline:
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
Do Not Allow Advertisers to Use My Personal information
